Pharma market access and commercialization consulting powered by data platforms
Precision AQ advises the world's top 30 pharmaceutical companies on market access, health economics, and drug launch strategy. The tech stack reveals a hybrid consulting + data-products operation: core analytics in R, SQL, and Snowflake; workflow automation via Salesforce, Workfront, and Informatica; and domain-specific tools like Veeva and Reltio. Marketing hiring (37 roles) dominates their active funnel, followed by data (8), sales (7), and engineering (5), suggesting a push to scale internal data products (DecoderX, AccessGenius) alongside traditional consulting delivery.
Notable leadership hires: Scientific Director, Medical Director, Art Director, Group Account Director, Account Director
Precision AQ is a commercialization advisory firm specializing in market access, health economics and outcomes research (HEOR), medical communications, and payer/provider strategy for pharmaceutical innovators. The firm has launched over 450 drugs across therapeutic areas and maintains trusted relationships with all 30 of the world's top pharma companies and leading biotechs. Operations span market access strategy, commercial consulting, omnichannel marketing solutions, medical affairs, investor relations, and data/analytics. The company is headquartered in New York and employs 1,001–5,000 people across the United States, India, and the Netherlands.
Core tools include R, SQL, Snowflake, and Informatica for data analytics; Salesforce and Workfront for CRM and project management; Veeva and Reltio for pharma-specific data; and Adobe Creative Suite (InDesign, Photoshop, XD, Illustrator) and Figma for design.
Precision AQ is headquartered in New York, NY, with active hiring in the United States, India, and the Netherlands.
Other companies in the same industry, closest in size